SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Organovo (ONVO)
ONVO 2.330+1.7%Oct 24 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JakeStraw12/14/2016 8:19:03 AM
1 Recommendation

Recommended By
FJB

   of 171
 
Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)
finance.yahoo.com

CosmoBio is one of Japan’s largest suppliers in the life science industry, and Organovo will work with CosmoBio’s Drug Discovery Services (DDS) team to gain direct access to customers and support projects throughout the Japanese biopharmaceutical industry.

“We’re committed to expanding our customer footprint in Asia, as four of the world’s Top 25 global pharmaceutical companies are located in Japan,” said Paul Gallant, general manager, Organovo. “CosmoBio is an ideal distribution partner for our liver and kidney tissue testing services because of their deep network, strong customer relationships and excellent track record selling the products and services of leading research tools companies.”
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News